PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against advanced melanoma before surgery
Disease control CompletedThis study tested whether giving a combination of targeted drugs (vemurafenib and cobimetinib) and an immunotherapy (atezolizumab) before surgery could help patients with high-risk stage III melanoma. 64 adults with advanced melanoma that had spread to lymph nodes took part. The …
Matched conditions: PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Lighter chemo before immune cell therapy shows promise in tough melanoma
Disease control CompletedThis study tested a new approach for people with advanced melanoma that cannot be removed by surgery or has spread. Doctors used a lower dose of two chemotherapy drugs (fludarabine and cyclophosphamide) to prepare the body, then infused the patient's own tumor-fighting immune cel…
Matched conditions: PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 26, 2026 03:53 UTC